(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MED365

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MED365

ST13

US500000097598349

Class

5

Filing

97598349

Registration

7306632

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

08/19/2025

Trademark type

Word

Nice classes

5

Filing date

09/20/2022

Registration date

02/13/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/13/2024

Last transaction

08/19/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/25/2022

First use in commerce

10/25/2022

Drawing code

4

Owner type

03

Owner location

Ronkonkoma, NY

Examiner

CAYCEDO, CATHERINE

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

S. P. (pessoa física)
S. P. (pessoa física)

Representatives

Shield Pharmaceuticals

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Allergy capsules; Allergy medication; Allergy medications; Allergy relief medication; Analgesic and muscle relaxant pharmaceutical preparations; Analgesic balm; Analgesic preparations; Analgesics; Anti-inflammatories; Anti-inflammatory and antipyretic preparations; Anti-inflammatory ointments; Anti-inflammatory preparations; Anti-inflammatory sprays; Cold sore treatment preparations; Dietary and nutritional supplements; Dietary supplements; Digestives for pharmaceutical purposes; Herbal supplements; Laxative suppositories; Laxatives; Sleeping pills/tablets; Allergy tablets; Amino acids for nutritional purposes; Anti-inflammatory gels; Anti-inflammatory salves; Antipyretic analgesics; Dietary fiber to aid digestion; Effervescent analgesic pharmaceutical preparations; First aid kits; Herbal supplements for sleeping problems; Homeopathic anti-inflammatory ointment; Ibuprofen for use as an oral analgesic; Liquid nutritional supplement; Medicinal drinks; Medicinal herbs; Medicinal tea; Multipurpose medicated antibiotic creamanalgesic balm and mentholated salve; Nasal drops for the treatment of allergies; Natural sleep aid preparations; Natural herbal supplements; Natural remedy preparations for the treatment of gastro-intestinal conditionshormonal and chemical imbalancessleep disorders; Non-medicated topical gel for the prevention and treatment of cold and flu; Oral analgesics; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating allergies; Pharmaceutical preparationsan analgesic for human consumption taken orally; Plasters for medical purposes; Preparations for treating colds; Protein dietary supplements; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Topical analgesic creams; Topical analgesics

Publications

History of USPTO decisions and trademark events.

23 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/18/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/18/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/18/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/13/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/13/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/12/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/11/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/01/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/30/2023

IUAF

USE AMENDMENT FILED

11/17/2023

EISU

TEAS STATEMENT OF USE RECEIVED

11/17/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/14/2023

LOPR

LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN

09/21/2023

LOPT

LETTER OF PROTEST EVIDENCE FORWARDED

09/13/2023

ISPO

WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST

09/13/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/24/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/22/2023

PUBO

PUBLISHED FOR OPPOSITION

08/22/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/02/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/14/2023

DOCK

ASSIGNED TO EXAMINER

06/30/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/26/2022

NWAP

NEW APPLICATION ENTERED

09/23/2022

Continuous trademark protection

Get notified about every new filing that threatens MED365 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.